News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
04 14 2021 GENEVA--(BUSINESS WIRE)--The Commons Project Foundation and the World Economic Forum today announced the global expansion of the CommonTrust Network (www.commontrustnetwork.org) to cover 32...
-
03 15 2021 Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods,...
-
03 11 2021 - Company to repurchase $900 million of its shares in first half of 2021At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
-
02 24 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new COVID-19 testing service that aids in providing insight into an individual's...
-
02 23 2021 --Daniel C. Stanzione to Retire from Board and as Lead Independent DirectorQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced changes in the leadership of its Board of Directors. Daniel C. Stanzione,...